DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 7, 1997, Pages 547-550

  Roa, Iván ^a   Villaseca, Miguel ^a   Araya, Juan C ^a   Roa, Juan ^a   De Arctxabala, Xabier ^b   Fuentealba, Patricia ^a   Melo, Angelica ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; ANEUPLOIDY; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; DIPLOIDY; DNA DETERMINATION; FEMALE; GALLBLADDER CARCINOMA; HUMAN; MALE; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; DIPLOIDY; DNA, NEOPLASM; FEMALE; GALLBLADDER; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PLOIDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030745519     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Vogelslein, B., and Kinzler, K. p53 function and dysfunction. Cell, 70: 523-526, 1992.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. p53 mutation in human cancers. Science (Washington DC), 253: 49-53, 1991.
3. Malkin, D., Li, F., Strong, L., Fraumeni, J., Nelson, C., Kim, D., and Kassel, J. Germ-line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasm. Science (Washington DC), 250: 1233-1238, 1990.
4. Li, F., Garber, J., Friend, S., Strong, L., Patenaude, A., Juengst, E., and Reilly, P. Recommendation on predictive testing for germ-line p53 mutations among cancer-prone individuals. J. Natl. Cancer Inst. (Bethesda), 84: 1156-1160, 1992.
5. Wistuba, I., Gazdar, A., Sugio, K., Roa, I., and Albores-Saavedra, J. p53 protein over-expression in gallbladder carcinoma and its precursor lesions. Hum. Pathol., 27: 360-365, 1996.
6. Wistuba, I., Gazdar, A., Sugio, K., Hung, J., Kishimoto, Y., Virmani, A., Roa, Y., Albores-Saavedra, J., and Gazdar, A. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res., 55: 2511-2115, 1995.
7. Oohashi, Y., Watanabe, H., Ajioka, Y., and Hatakeyama, K. p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol. Int., 45: 58-65, 1995.
8. Frentz, G. Flow cytometric DNA analysis of normal, premalignant and malignant human epidermal tissues. Acta Dermato-Venereol. Suppl. 129: 1-44, 1987.
9. Hiddemann, W., Von Bassewitz, D., Kleinemeier, H., Schulte, E., Hauss, J., Lingemann, B., Bhchner, T., and Grundmann, E. DNA stemline heterogeneity in colorectal cancer. Cancer (Phila.), 58: 258-263, 1986.
10. Jungberg, L., Stenling, R., and Roos, G. DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer (Phila.), 56: 503-508, 1985.
11. Korenaga, D., Haraguchi, M., Okamura, T., Sugimachi, K., Kaibara, N., Koga, S., and Inokuchi, K. Consistency of DNA ploidy between primary and recurrent gastric carcinoma. Cancer Res., 46: 1544-1546, 1986.
12. Hedley, D., Friedlander, M. L., and Taylor, I. W. Application of the DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry, 6: 327-333, 1985.
13. Giaretti, W., Danova, M., Geido, E., Mazzini, G., Sciarellero, S., Aste, H., Scivetti, P., Riccardi, A., Marsano, B., and Merlo, S. Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer (Phila.), 67: 1931-1927, 1991.
14. Inversen, E. Flow cytometric deoxyribonucleic acid index: a prognostic factor in endometrial carcinoma. Am. J. Obstet. Gynecol., 155: 770-776, 1986.
15. Renter, G., Comelisse, C., Aartsen, E., Mooy, W., Hermans, J., Heintz, A., and Fleuren, G. DNA ploidy used as prognostic factor in low stage carcinoma of the uterine cervix. Gynecol. Oncol., 39: 181-185, 1990.
16. Rognum, T., Lund, E., Meling, G., and Langmark, F. Near to diploid large bowel carcinoma have better 5-year survival rate than aneuploid ones. Cancer (Phila.), 68: 1081-1091, 1991.
17. Fallenius, G., Auer, U., and Carstensen, J. Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer (Phila.), 62: 331-341, 1988.
18. Thorud, E., Fossa, S., Vaage, S., Kalhuss, O., Kudsen, S., Dormer, O., and Schoaib, M. Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer (Phila.), 57: 808-811, 1986.
19. Atkin, N. B., and Kay, R. Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1465 cases. Br. J. Cancer, 40: 210-221, 1979.
20. Schutte, B., Reynders, M. M., Wiggers, T., Arends, J., Volovics, L., Bosman, F., and Blijham, G. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res., 47: 5494-5496, 1987.
21. Jones, D., Moore, M., and Schofield, P. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br. J. Surg., 75: 28-33, 1988.
22. Roa, I., Araya, J., Wistuba, I., Willaseca, M., and De Aretxabala, X. DNA content in gallbladder carcinoma. A flow cytometric study of 96 cases. Histopathology, 23: 459-464, 1993.
23. Roa, I., Araya, J., Wistuba, I., Willaseca, M., and De Aretxabala, X. Epithelial lesions associated to gallbladder carcinoma. Rev. Med. Chile, 121: 21-29, 1992.
24. Roa, I., Araya, I., Wistuba, O., and De Aretxabala, X. Gallbladder carcinoma. Pathological considerations. Rev. Med. Chile, 118: 572-579, 1990.
25. Garrido, L., de Aretxabala, I., Roa, I., and Burgos, L. Prognostic factors in subserosal gallbladder carcinoma. Rev. Chil. Cir., 48: 483-489, 1996.
26. Roa, I., Araya, J., Shiraishi, T., Yatani, R., Wistuba, I., Willaseca, M., and De Aretxabala, X. Cellular cycle phases analyzed by flow cytometry. Rev. Med. Chile, 121: 881-888, 1993.
27. Ljungberg, B., Stenling, R., and Roos, G. DNA content and prognosis in renal carcinoma. A comparison between primary tumors and metastasis. Cancer (Phila.) 57: 2346-2350, 1986.
28. Watson, J. Molecular Biology of the Gene, 4th Ed, pp. 1006-1047. Menlo Park, CA: The Benjamin/Cummings Publishing Co., 1987.
29. Nakopoulou, L., Constantinides, C., Papandropoulos, J., Theodoropoulos, G., Tzonou, A., Giannopoulus, D., Zervas, A., and Dimopoulos, C. Evaluation of overexpression of p53 tumors suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Urology, 46: 334-340, 1995.
30. Auer, G., Heselmeyer, K., Steinbeck, R., Munck, E., and Zetterberg, A. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Arch., 424: 343-347, 1994.
31. el Naggar, A., Lai, S., Luna, M., Zhou, X., and Weber, R. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int. J. Cancer, 64: 196-201, 1995.
32. Casson, A., McCuaig, S., Craig, I., Ayed, A., Inculet, R., Kerkvliet, N., and O'Malley, F. Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: a prospective study. J. Surg. Oncol., 56: 13-20, 1994.
33. Tamura, G., Kihana, T., Nomura, K., Terada, M., Sugimura, T., and Hirohashi, S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res., 57: 3056-3058, 1991.